InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
7
Disclosed sells
0
T+90 hit rate
8%
T+90 mean return
-25.2%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by BARER SOL J. Insider active across 3 companies, notably Teva Pharmaceutical Industries Ltd. Cumulatively, 18 filings have been logged. Breakdown: 7 buys · 0 sell. Total volume traded: €433k. History available since 21 December 2021. The latest transaction was filed on 30 March 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations18 total
21,739 sharesOrdinary SharesSEC:0001193125-26-261715:0
37,598 sharesOrdinary SharesSEC:0000950170-24-074001:0
28,162 sharesOrdinary SharesSEC:0001209191-23-044769:0
400,000 shares@ US$0.410316.9% of flowCommon StockSEC:0001209191-23-021889:0
Ideal exit: 25 Dec 2023 (T+270)
75,000 shares@ US$0.47893.9% of flowCommon StockSEC:0001209191-22-057746:0
Ideal exit: 14 Aug 2023 (T+270)
25,791 sharesOrdinary SharesSEC:0001209191-22-037243:0
20,720 shares@ US$2.22496.1% of flowCommon StockSEC:0001209191-22-033727:0
Ideal exit: 27 Feb 2023 (T+270)
10,000 shares@ US$2.66533.4% of flowCommon StockSEC:0001209191-22-020914:0
Ideal exit: 18 Dec 2022 (T+270)
30,000 shares@ US$2.419.3% of flowCommon StockSEC:0001209191-22-020766:0
Ideal exit: 17 Dec 2022 (T+270)
30,000 shares@ US$2.1368.2% of flowCommon StockSEC:0001209191-22-020522:0
Ideal exit: 16 Dec 2022 (T+270)
30,000 shares@ US$2.1078.1% of flowCommon StockSEC:0001209191-22-020256:0
Ideal exit: 13 Dec 2022 (T+270)
50,000 shares@ US$5.1725.7% of flowCommon StockSEC:0001209191-21-070879
50,000 shares@ US$5.1732.5% of flowCommon StockSEC:0001209191-21-070879:0
22,565 sharesOrdinary SharesSEC:0001209191-21-039367
22,565 sharesOrdinary SharesSEC:0001209191-21-039367:0
17,565 sharesOrdinary SharesSEC:0001209191-21-038811:0
17,565 sharesOrdinary SharesSEC:0001209191-21-038811
1 sharesCommon StockSEC:0001615774-16-004023:0
18 of 18 declarations
About BARER SOL J
Sol J Barer is a director at Teva Pharmaceutical Industries Ltd and NexImmune, Inc.
